FLG client, Cortexyme, a privately held, clinical-stage pharmaceutical company developing therapeutics to alter the course of Alzheimer’s disease (AD) and other degenerative disorders, announced effective January 2019, two key leadership appointments. Veteran clinical development professional Michael Detke, M.D., Ph.D., has been appointed Chief Medical Officer and Chris Lowe, a longtime…Read More
“Mayvenn brought on FLG at a time when our finance department was in really bad shape. Within sixty days of coming on-board, our books were completely cleaned up, compliance and processes completely re-designed, and the right, full-time hires were made to ensure continuity. FLG was able to pair us with a partner, Patty Fukami, who had the appropriate expertise, but who was also a good cultural fit. This firm is highly professional and has integrity. I’m very pleased with them and recommend them to any company looking to either turn around or take their finance department to the next level.”
